Aquila Diagnostics Systems is Biotechnology in Canada that focus on deoxyribonucleic acid business. Founded in 2009. They cover business area such as developer, molecular diagnostic testing system, infectious and pathogenic agent, DNA, deoxyribonucleic acid, amplification, real-time PCR (polymerase chain reaction, healthcare provider, accurate, timely, low cost, multi-parameter testing.
2009
( 15 years old in 2024 )
Deoxyribonucleic Acid
-
4-034 National Institute for Nanotechnology
11421 Saskatchewan Drive
Edmonton, Alberta T6G 2M9
Canada
Private
developermolecular diagnostic testing systeminfectious and pathogenic agentDNAdeoxyribonucleic acidamplificationreal-time PCR (polymerase chain reactionhealthcare provideraccurate, timely, low costmulti-parameter testing
* We use standard office opening hours in near Aquila Diagnostics Systems's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Aquila Diagnostics Systems is Biotechnology business from Canada that founded in 2009 (15 years old in 2024), Aquila Diagnostics Systems business is focusing on Deoxyribonucleic Acid.
Aquila Diagnostics Systems headquarter office and corporate office address is located in 4-034 National Institute for Nanotechnology 11421 Saskatchewan Drive Edmonton, Alberta T6G 2M9 Canada.
Aquila Diagnostics Systems was founded in Canada.
In 2024, Aquila Diagnostics Systems is currently focus on deoxyribonucleic acid sector.
Above is snippet of Google Trends for "deoxyribonucleic acid" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Aquila Diagnostics Systems, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
